GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Beyond Air Inc (NAS:XAIR) » Definitions » Price-to-Tangible-Book

Beyond Air (Beyond Air) Price-to-Tangible-Book : 2.14 (As of Apr. 28, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Beyond Air Price-to-Tangible-Book?

As of today (2024-04-28), Beyond Air's share price is $1.165. Beyond Air's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $0.55. Hence, Beyond Air's Price to Tangible Book Ratio of today is 2.14.

The historical rank and industry rank for Beyond Air's Price-to-Tangible-Book or its related term are showing as below:

XAIR' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.12   Med: 5.72   Max: 215.83
Current: 2.12

During the past 9 years, Beyond Air's highest Price to Tangible Book Ratio was 215.83. The lowest was 2.12. And the median was 5.72.

XAIR's Price-to-Tangible-Book is ranked better than
58.46% of 703 companies
in the Medical Devices & Instruments industry
Industry Median: 2.66 vs XAIR: 2.12

A closely related ratio is called PB Ratio. As of today, Beyond Air's share price is $1.165. Beyond Air's Book Value per Sharefor the quarter that ended in Dec. 2023 was $0.59. Hence, Beyond Air's P/B Ratio of today is 1.98.


Beyond Air Price-to-Tangible-Book Historical Data

The historical data trend for Beyond Air's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beyond Air Price-to-Tangible-Book Chart

Beyond Air Annual Data
Trend Jun15 Jun16 Dec17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only 11.85 7.27 3.99 2.82 5.72

Beyond Air Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.95 5.72 3.99 3.05 3.60

Competitive Comparison of Beyond Air's Price-to-Tangible-Book

For the Medical Devices subindustry, Beyond Air's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beyond Air's Price-to-Tangible-Book Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Beyond Air's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Beyond Air's Price-to-Tangible-Book falls into.



Beyond Air Price-to-Tangible-Book Calculation

Beyond Air's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=1.165/0.545
=2.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Beyond Air Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Beyond Air's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Beyond Air (Beyond Air) Business Description

Traded in Other Exchanges
Address
900 Stewart Avenue, Suite 301, Garden City, New York, NY, USA, 11530
Beyond Air Inc is a clinical-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
Executives
Amir Avniel director, officer: President & CEO 2 ILAN RAMON, SCIENCE PARK, NESS ZIONA L3 7403635
Jeff Lynn Myers officer: Chief Medical Officer C/O BEYOND AIR, INC., 900 STEWART AVENUE, SUITE 301, GARDEN CITY NY 11530
Robert Carey director HORIZON PHARMA, INC., 520 LAKE COOK ROAD, SUITE 520, DEERFIELD IL 60062
Steven A. Lisi director 2 ILAN RAMON, SCIENCE PARK, NESS ZIONA L3 7403635
Michael A. Gaul officer: Chief Operating Officer 425 MARTINGALE ROAD, SUITE 1000, SCHAUMBURG IL 60173-2213
William P Forbes director C/O SALIX PHARMACEUTICALS, LTD., 8510 COLONNADE CENTER DRIVE, RALEIGH NC 27615
Yoori Lee director C/O AIT THERAPEUTICS, INC., 500 MAMARONECK AVENUE, HARRISON NY 10528
Ron Bentsur director 750 LEXINGTON AVE, 20TH FL, NEW YORK NY 10022
Erick Lucera director 138 THISTLE ROAD, NORTH ANDOVER MA 08145
Douglas Quinton Larson officer: Chief Financial Officer BEYOND AIR, INC., 900 STEWART AVENUE, SUITE 301, GARDEN CITY NY 11530
Douglas Beck officer: Chief Financial Officer C/O IBIO, INC., 9 INNOVATION WAY, SUITE 100, NEWARK DE 19711
Ari Raved director 2 ILAN RAMON, SCIENCE PARK, NESS ZIONA L3 7403635
Jerome B Zeldis director 8767 E. VIA DE VENTURA, SUITE 190, SCOTTSDALE AZ 85258
David Grossman director 2 ILAN RAMON, SCIENCE PARK, NESS ZIONA L3 7403635
Haim Aviv officer: Chief Financial Officer 2 ILAN RAMON, SCIENCE PARK, NESS ZIONA L3 7403635